REGULATED PRESS RELEASE published on 10/30/2023 at 18:05, 2 years 10 months ago Eiffage signs a real estate development contract with the Hérault ICC for the future Cambacérès campus in Montpellier
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 2 years 10 months ago Eiffage, in consortium with Lorraine Énergie and DEF, carries out the work of the technical macro-lot for the restoration of Notre-Dame de Paris Cathedral
REGULATED PRESS RELEASE published on 10/25/2023 at 18:45, 2 years 10 months ago Eiffage strengthens its position in Getlink and crosses the threshold of 20% of the capital
REGULATED PRESS RELEASE published on 10/23/2023 at 17:40, 2 years 10 months ago Eiffage breaks ground on the future 25 000m2 oncology innovation-focused building for Kadans Science Partner on the Campus Grand Parc in Villejuif
REGULATED PRESS RELEASE published on 10/18/2023 at 17:40, 2 years 10 months ago Eiffage wins a contract to manufacture 76 transition pieces for Baltic Power, Poland’s first offshore wind farm
REGULATED PRESS RELEASE published on 10/17/2023 at 17:40, 2 years 10 months ago Eiffage is pursuing its growth strategy in Europe with the acquisition in Germany of Salvia Group GmbH in the energy field
REGULATED PRESS RELEASE published on 10/16/2023 at 17:40, 2 years 10 months ago Eiffage consortium wins the contract for Phase 2 of ACC’s gigafactory for electric vehicle batteries in Douvrin in a deal worth almost €100 million
Published on 08/31/2026 at 17:22, 3 hours 19 minutes ago ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison
Published on 08/31/2026 at 15:50, 4 hours 51 minutes ago Sarama Resources - Grant of Equity Incentives
Published on 08/31/2026 at 15:00, 5 hours 41 minutes ago Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 14:30, 6 hours 11 minutes ago While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles
Published on 08/31/2026 at 19:31, 1 hour 10 minutes ago DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 1 hour 26 minutes ago CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 18:20, 2 hours 21 minutes ago CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:06, 2 hours 35 minutes ago MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026
Published on 08/31/2026 at 18:04, 2 hours 36 minutes ago PRIMARY HYDROGEN EXPANDS CUMBERLAND BASIN POSITION WITH STAKING OF THE WALLACE PROJECT, NOVA SCOTIA
Published on 08/31/2026 at 17:45, 2 hours 56 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 12:00, 8 hours 41 minutes ago Capital increase through exercise of subscription rights
Published on 08/31/2026 at 07:00, 13 hours 41 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027
